Your new experience awaits. Try the new design now and help us make it even better

SYSTEMATIC REVIEW article

Front. Endocrinol.

Sec. Clinical Diabetes

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1599423

This article is part of the Research TopicHighlights in Diabetes NephropathyView all 20 articles

Correlation of Serum Irisin Levels with Diabetic Nephropathy: An Exhaustive Systematic Appraisal and Meta-Analytical Investigation

Provisionally accepted
Yuan  DengYuan Deng1*Yinhui  ShenYinhui Shen1Yuchen  WuYuchen Wu1Min  WenMin Wen1Fang  WangFang Wang2
  • 1Yueyang Vocational Technical College, Hunan, China
  • 2Xianning Vocational and Technical College, Xianning, Hubei Province, China

The final, formatted version of the article will be published soon.

Objective: To comprehensively and accurately explore the association between serum irisin levels and DN through a systematic review and meta - analysis. Methods: The research was conducted following the Meta - analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Studies were included if they were randomized controlled trials (RCTs) or observational studies that stratified Type 2 diabetes mellitus (T2DM) patients based on the presence or absence of DN, measured serum irisin levels in both groups, and provided data in a suitable format. Two independent reviewers performed literature screening, data extraction, and quality assessment. The Jadad scale was used for RCTs, and the Newcastle - Ottawa Scale (NOS) was applied for cohort and case - control studies. Statistical analysis was carried out using RevMan 5.3 software, with heterogeneity evaluated by Q and I² tests, and appropriate models (fixed - effects or random - effects) selected accordingly. Results: A total of seven studies, comprising 453 DN patients and 346 non-DN controls, were included in the final meta-analysis. The pooled results demonstrated that serum irisin levels were significantly lower in patients with diabetic nephropathy, particularly those with more advanced stages of albuminuria. Specifically, irisin levels were significantly reduced in patients with microalbuminuria and macroalbuminuria compared to those with normoalbuminuria. Furthermore, a direct comparison between microalbuminuria and macroalbuminuria also revealed significantly lower irisin levels in the latter group. In terms of renal function, patients with eGFR < 60 mL/min/1.73 m² exhibited lower irisin concentrations than those with preserved renal function, though this difference was not statistically significant. Conclusions: This meta - analysis provides evidence for an association between serum irisin levels and DN. Lower serum irisin levels were related to more severe albuminuria and decreased eGFR in T2DM patients. However, considering the limitations of this study, such as potential missing data and methodological differences, further large - scale, multi - center, and high - quality RCTs are needed to validate these findings and elucidate the underlying mechanisms.

Keywords: type 2 diabetes mellitus, irisin, diabetic nephropathy, Systematic review, metaanalysis

Received: 28 Mar 2025; Accepted: 07 Aug 2025.

Copyright: © 2025 Deng, Shen, Wu, Wen and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yuan Deng, Yueyang Vocational Technical College, Hunan, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.